Drug treatment is any planned intervention designed to help a person stop using substances, manage withdrawal, and build the skills needed to stay in recovery. It spans a wide range of services, from weekly outpatient therapy sessions to round-the-clock residential care, and often combines behavioral therapy with medication. No single approach works for everyone, so treatment is typically matched to the severity of a person’s substance use, their mental health, and their life circumstances.
How Treatment Is Structured
Addiction care is organized into levels of intensity, and clinicians match a person to the right level based on their medical needs, risk of relapse, and daily stability. The main tiers look like this:
- Early intervention: Preventive services for people who are at risk but may not yet have a diagnosable disorder.
- Standard outpatient: Fewer than 9 hours of therapy per week, allowing you to maintain work, school, and family routines.
- Intensive outpatient: 9 to 19 hours of structured therapy per week, still without overnight stays.
- Partial hospitalization: 20 or more hours of clinical care per week, sometimes called “day treatment.”
- Residential treatment: 24-hour live-in programs with continuous medical and therapeutic support in a substance-free environment.
People often move between levels as they progress. Someone might start in a residential program during the most acute phase and step down to intensive outpatient once they’re stable enough to live at home.
Medical Detoxification
For many substances, treatment begins with detox, the process of clearing the drug from the body while managing withdrawal symptoms under medical supervision. Detox is not treatment on its own. It’s the stabilization phase that makes the rest of treatment possible.
During detox for opioid dependence, medical staff typically monitor patients three to four times per day, tracking symptoms with standardized scales. Medications can be used to ease withdrawal, including the same drugs later used in longer-term recovery support. For alcohol dependence, monitoring is similarly frequent, with withdrawal assessments every four hours for at least three days, since alcohol withdrawal carries risks like seizures that require close attention. The goal is to get a person medically stable and ready to engage in the behavioral and therapeutic work that follows.
Medications Used in Recovery
Medication is a core part of treatment for certain substance use disorders, not a shortcut or a replacement for therapy. For opioid use disorder, three FDA-approved medications are available, each working on the same receptors in the brain that opioids target:
- Methadone activates those receptors at a steady, controlled level, preventing withdrawal and reducing cravings without producing a high at therapeutic doses.
- Buprenorphine partially activates the same receptors, offering a ceiling effect that limits its potential for misuse.
- Naltrexone blocks those receptors entirely, so opioids produce no effect if used. Naltrexone is also approved for alcohol use disorder, making it useful for people dealing with both.
These medications are most effective when combined with counseling and behavioral support. They reduce cravings and help normalize brain chemistry, giving people the stability to focus on building new habits and addressing the underlying drivers of their substance use.
Behavioral Therapies
Talk therapy is the backbone of most treatment programs, and several approaches have strong evidence behind them.
Cognitive-behavioral therapy (CBT) teaches people to identify the thought patterns and situations that trigger substance use, then develop new coping strategies to replace those behaviors. One of its advantages is durability: outcomes tend to continue improving even after sessions end, suggesting that the skills people learn stick with them over time.
Motivational interviewing takes a different approach. Instead of teaching coping skills directly, it helps people work through their own ambivalence about change. A therapist guides the conversation so that motivation comes from within rather than from external pressure. A condensed four-session version called Motivational Enhancement Therapy produced strong outcomes in large clinical trials and is now widely used.
Research consistently shows that staying in treatment long enough matters. Studies have documented that 90 days or more of treatment is the threshold associated with meaningfully better outcomes. Shorter stays can still help, but the evidence favors sustained engagement.
Dual Diagnosis Treatment
Roughly half of people with a substance use disorder also have a co-occurring mental health condition like depression, anxiety, PTSD, or bipolar disorder. When these conditions exist together, treating only one rarely works well.
Integrated treatment programs address both issues simultaneously with a single treatment team. This matters because when substance abuse treatment is provided separately from mental health care, people often get conflicting advice, fall through the cracks between providers, or drop out entirely. In an integrated model, assessments screen for both conditions from the start, and the same clinicians develop a unified plan covering medication, therapy, and recovery support. SAMHSA, the federal agency overseeing behavioral health, has found that this approach leads to better recovery rates for both conditions and reduces overall costs compared to treating them in parallel.
Treatment progresses through stages. Early on, the focus is on building motivation and trust. As a person becomes more engaged, cognitive-behavioral counseling and relapse prevention take center stage. Services are available in individual, group, family, and self-help formats, adapting to what works best at each point in recovery.
Complementary Approaches
Many treatment programs now include complementary therapies alongside standard clinical care. These aren’t replacements for evidence-based treatment, but they can support recovery in meaningful ways.
Mindfulness-based relapse prevention (MBRP) is one of the most studied. Developed specifically for people with substance use disorders, it combines meditation techniques with cognitive therapy relapse prevention skills. A typical course runs eight weekly group sessions, each involving guided practice, discussion, and exercises to take home. It’s designed for people who have already completed initial treatment and are focused on maintaining their progress.
Biofeedback, which trains people to consciously regulate functions like breathing and heart rate, is used in some programs to address the stress and anxiety that fuel relapse. Preliminary evidence suggests it may help reduce cravings, depression, and anxiety in people recovering from substance use, though research is still limited.
What Recovery Looks Like Long-Term
Addiction is a chronic condition, and its relapse rates are comparable to those of other chronic diseases like hypertension and asthma. This framing matters because relapse doesn’t mean treatment failed. It means the treatment plan needs adjusting, the same way a doctor would adjust a blood pressure medication that stopped working.
Large-scale outcome studies have found roughly a 42% reduction in indicators of drug use among people who complete treatment. That number is consistent with what clinicians generally reference as “about 50%” improvement, with variation depending on the substance, severity, and duration of care. Factors that improve long-term odds include longer treatment stays, strong social support, continued participation in aftercare programs, and addressing co-occurring mental health conditions.
Recovery is not a single event. It’s an ongoing process that often involves stepping through different levels of care, trying different therapeutic approaches, and building a life where sobriety is sustainable. The most effective treatment programs recognize this and plan for long-term support rather than treating discharge as the finish line.